IL6 and non-small cell lung carcinoma: Similarly, we found that EG0029 significantly inhibited the activation of the SDF-1/CXCR4 and IL-6/STAT3 pathways, decreased the proliferation and migration of NSCLC cells, and further reduced the radiation resistance of NSCLC cells.